Kilian M. Gust

Oncological Followup After Radical Cystectomy for Bladder Cancer—Is There Any Benefit?

Bjoern G. Volkmer, Rainer Kuefer, Georg Bartsch et al. · The Journal of Urology · 2009 · 123 citations

Medicine, Oncology, Surgery +11

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer

David D’Andrea, Francesco Soria, Sonja Zehetmayer et al. · British Journal of Urology · 2019 · 107 citations · Full text

Medicine, Oncology, Urology +15

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

Richard E. Hautmann, Bjoern G. Volkmer, Kilian M. Gust · World Journal of Urology · 2009 · 97 citations

Medicine, Surgery, Urology +13

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Kilian M. Gust, David J. McConkey, Shannon Awrey et al. · Molecular Cancer Therapeutics · 2013 · 94 citations · Full text

Medicine, Oncology, Pharmacology +15

Upper Urinary Tract Recurrence After Radical Cystectomy for Bladder Cancer—Who is at Risk?

Bjoern G. Volkmer, Thomas Schnoeller, Rainer Kuefer et al. · The Journal of Urology · 2009 · 91 citations

Medicine, Surgery, Urology +10